Sort
64,565 grants matching “drug discovery”
Phagocytosis-Pulmonary Alveolar Macrophages
$744,865Thomas Peter Stossel · Brigham And Women'S Hospital · R01 · FY2008 · HL
Biological Magnetic Resonance Data Bank
$744,771Jeffrey C Hoch · University Of Connecticut Sch Of Med/Dnt · R24 · FY2025 · GM
Chemical probes of vulnerable pathways in antibiotic-resistant pathogens
$744,764Tanya Parish · Access To Advanced Health Institute · R01 · FY2015 · AI
Development and Regulation of Emotion in Primates
$744,755Ned H Kalin · University Of Wisconsin-Madison · R01 · FY2021 · MH
Epstein-Barr Virus LMP-1 Mediated Oncogenicity
$744,728Elliott D Kieff · Brigham And Women'S Hospital · R01 · FY2007 · CA
Uncovering novel biological processes and pathogenic mechanisms for glaucoma
$744,725Ayellet Vered Segre · Massachusetts Eye And Ear Infirmary · R01 · FY2021 · EY
Translational Geroscience Network
$744,685Robert John Pignolo · Mayo Clinic Rochester · R33 · FY2024 · AG
Epidemiologic Studies
$744,671Stephen B Gruber · University Of Michigan At Ann Arbor · U19 · FY2011 · CA
"A Flexible and Scalable HTS Platform for CNS Probe Discovery"
$744,559Gavin R Rumbaugh · Scripps Florida · R33 · FY2016 · NS
Administration
$744,507Mark A Israel · Dartmouth College · P30 · FY2015 · CA
Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases
$744,393Qiang Gong · Aptitude Medical Systems, Inc. · R44 · FY2022 · EY
Compact, Neon/Cryocooled NMR Magnets Assembled from Superconducting YBCO Annuli
$744,354Yukikazu Na Iwasa · Massachusetts Institute Of Technology · R01 · FY2010 · EB
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
$744,336Kim L Brouwer · Univ Of North Carolina Chapel Hill · T32 · FY2023 · GM
Comprehensive but simple encoding of bioassays to accelerate translational drug discovery
$744,321Barry A Bunin · Collaborative Drug Discovery, Inc. · R44 · FY2018 · TR
Ligand discovery for delineating cholesterol homeostasis in the brain
$744,264Steven H Liang · Emory University · R01 · FY2025 · AG
Targeting cardiovascular events to improve patient outcomes after sepsis
$744,234Allan J. Walkey · Boston University Medical Campus · R01 · FY2018 · HL
Washington Entrepreneurial Research Evaluation and Commercialization Hub
$744,200Rodney J.y. Ho · University Of Washington · U01 · FY2020 · HL
Epigenetics of severe asthma
$744,199Pandurangan Vijayanand · La Jolla Institute For Immunology · R01 · FY2018 · HL
Center for Humanized Mice
$744,154Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2017 · OD
Development of Mirror-Image Natural Products as Antiarrhythmic Therapeutics
$744,145Jeffrey Nicholas Johnston · Vanderbilt University · R01 · FY2025 · HL
Novel Drug Discovery against P. falciparum ENR
$744,131James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2008 · AI
Mechanisms of Maladaptation in Heart Failure
$744,055Howard A Rockman · Duke University · R01 · FY2021 · HL
BIODIVERSITY UTILIZATION IN MADAGASCAR AND SURINAME
$744,000Virginia Polytechnic Inst And St Univ · U01 · FY2001 · TW
Antifungal therapy against drug resistant fungal pathogens.
$743,940Esteban Edward Mena · Lifepharms, Inc. · R44 · FY2016 · AI
D-ISN: TRACK 1: Collaborative Research: Discovery, Analysis, and Disruption of Illicit Narcotic Supply Networks
$743,806Subramanian Raghavan · University Of Maryland, College Park · · FY2020 · ENG